Albert Hsu was named director of investments for the $1.1 billion Ludwig Institute of Cancer Research foundation, New York, effective in March. He will be involved in spending policy and asset allocation and will be due diligence manager. He replaces Chris Setten, who was named vice president at Goldman Sachs.
Mr. Hsu was principal-trust investments for the $9 billion pension fund at Xerox Corp., which has not yet found a replacement.
